| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84556 |
CAS: 1870916-87-2，Mal-Val-Ala-PAB，马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
182 |
WYQ |
2024-12-19 |
| 84557 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
148 |
zyl |
2024-12-19 |
| 84558 |
SuO-Val-Cit-PAB-MMAE， ADC试剂 |
164 |
kx |
2024-12-19 |
| 84559 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
150 |
zyl |
2024-12-19 |
| 84560 |
CAS: 2348405-93-4，DBCO-PEG4-Val-Ala-PAB-PNP |
134 |
WYQ |
2024-12-19 |
| 84561 |
CAS: 2348405-92-3，DBCO-PEG4-Val-Ala-PAB |
167 |
WYQ |
2024-12-19 |
| 84562 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
158 |
zyl |
2024-12-19 |
| 84563 |
Azido-PEG4-Val-Ala-PAB，分子式：C29H48N8O9 |
162 |
WYQ |
2024-12-19 |
| 84564 |
cas:2055896-86-9，MC-Val-Cit-PAB-tubulysin5a ， ADC试剂 |
171 |
kx |
2024-12-19 |
| 84565 |
Azido-PEG8-Val-Cit-PAB-PNP |
151 |
zyl |
2024-12-19 |
| 84566 |
cas:2055896-83-6，MC-Val-Cit-PAB-carfilzomib ， ADC试剂 |
158 |
kx |
2024-12-19 |
| 84567 |
MAL-di-EG-Val-Cit-PAB-MMAF， ADC试剂 |
152 |
kx |
2024-12-19 |
| 84568 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
176 |
zyl |
2024-12-19 |
| 84569 |
Hydrazone-doxorubicin， ADC试剂 |
298 |
kx |
2024-12-19 |
| 84570 |
DBCO-C4-Val-Cit-PABC-PNP |
164 |
zyl |
2024-12-19 |
| 84571 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
155 |
zyl |
2024-12-19 |
| 84572 |
cas:170908-81-3，DOTA-NHS ester ，1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
136 |
kx |
2024-12-19 |
| 84573 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
152 |
zyl |
2024-12-19 |
| 84574 |
cas:2259318-50-6，MA-PEG4-VA-PBD ， ADC试剂 |
236 |
kx |
2024-12-19 |
| 84575 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
116 |
WYQ |
2024-12-19 |
| 84576 |
CAS: 2768446-73-5，DBCO-Val-Cit-PAB-MMAE |
149 |
WYQ |
2024-12-19 |
| 84577 |
MC-vc-PAB-C6-a-amanitin， ADC试剂 |
155 |
kx |
2024-12-19 |
| 84578 |
cas:663598-98-9，2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate，ADC定制 |
153 |
wyh |
2024-12-19 |
| 84579 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
156 |
zyl |
2024-12-19 |
| 84580 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate，ADC定制 |
177 |
wyh |
2024-12-19 |
| 84581 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
175 |
zyl |
2024-12-19 |
| 84582 |
Gly3-vc-PAB-MMAE， ADC试剂 |
200 |
kx |
2024-12-19 |
| 84583 |
CAS: 1869126-64-6， Azido-PEG4-Val-Cit-PAB-MMAE |
166 |
WYQ |
2024-12-19 |
| 84584 |
cas:2353409-54-6 ， Mal-amido-PEG8-Val-Gly，ADC定制 |
186 |
wyh |
2024-12-19 |
| 84585 |
Azido-PEG4-Val-Ala-PAB-PNP |
187 |
zyl |
2024-12-19 |
| 84586 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
145 |
h |
2024-12-19 |
| 84587 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid，ADC定制 |
133 |
wyh |
2024-12-19 |
| 84588 |
CAS: 1343476-44-7，Val-Ala-PAB-OH |
138 |
WYQ |
2024-12-19 |
| 84589 |
MC-PBD， ADC试剂 |
169 |
kx |
2024-12-19 |
| 84590 |
Mal-Val-Ala-PAB的介绍 |
174 |
zyl |
2024-12-19 |
| 84591 |
DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 |
156 |
h |
2024-12-19 |
| 84592 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
149 |
WYQ |
2024-12-19 |
| 84593 |
Arm-DOTA-B72.3 |
158 |
h |
2024-12-19 |
| 84594 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
166 |
zyl |
2024-12-19 |
| 84595 |
(Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 |
242 |
h |
2024-12-19 |
| 84596 |
1801838-28-7，Mc-vc-PAB-SN38，化合物MC-VC-PAB-SN38 |
160 |
kx |
2024-12-19 |
| 84597 |
DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 |
161 |
h |
2024-12-19 |
| 84598 |
CAS: 863971-17-9，MC-Val-Cit-PAB-MMAF |
172 |
WYQ |
2024-12-19 |
| 84599 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
203 |
zyl |
2024-12-19 |
| 84600 |
DBCO-PEG4-vc-PAB-MMAE， ADC试剂 |
201 |
kx |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询